Price: 100 Per bottles 20 Tablets INR/Bottle
Afanat is used to treatment of non-small cell lung carcinomaÂ (NSCLC).Â Itbecomes to theÂ tyrosine kinase inhibitorÂ family of the drug. It is takenby mouth. It is primarily used to treat cases of NSCLC that harbor variation intheÂ epidermal growth factor receptorÂ (EGFR) chromosome. Afatinib is an effective and selective, irreversible ErbBfamily blocker. Afatinib covalently binds to and irreversibly blocks indicatingfrom all homo and heterodimers formed by the ErbB family members EGFR (ErbB1),HER2 (ErbB2), ErbB3 and ErbB4. Â Afatinib covalently binds to the kinase rule of EGFR (ErbB1), HER2 (ErbB2), andHER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in the down-regulation of ErbB in.
non-small cell lung carcinoma